VeriMoms-spider oligopeptide-1 est-il sûr pendant la grossesse ?
No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR reproductive safety finding for oligopeptide-1/EGF; no human teratogenic data. Peptides such as EGF are large biomolecules with low expected dermal penetration and no published reproductive hazard signals in regulatory sources or the peer-reviewed literature searched (PubMed). Sources: ECHA Annex VI (no harmonised classification), PubMed (no reproductive hazard publications), CosIng/PubChem (ingredient identity and peptide nature).
Related ingredients
Frequently asked questions
- s-spider oligopeptide-1 est-il sûr pendant la grossesse ?
- No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR reproductive safety finding for oligopeptide-1/EGF; no human teratogenic data. Peptides such as EGF are large biomolecules with low expected dermal penetration and no published reproductive hazard signals in regulatory sources or the peer-reviewed literature searched (PubMed). Sources: ECHA Annex VI (no harmonised classification), PubMed (no reproductive hazard publications), CosIng/PubChem (ingredient identity and peptide nature).
- s-spider oligopeptide-1 est-il sûr pendant l'allaitement ?
- No regulatory or peer-reviewed evidence of reproductive or lactation-specific hazards for oligopeptide-1/EGF. As a peptide with low systemic absorption from topical use, there is no demonstrated mechanism or data indicating transfer into breast milk or lactation-related effects in mother or infant. Sources: CIR/SCCS databases (no adverse findings), PubMed (no lactation transfer data indicating hazard), CosIng.
- s-spider oligopeptide-1 est-il sûr pour la peau de bébé ?
- Hazard and mechanism: no evidence of developmental or reproductive toxicity specific to infants. Exposure: while adult dermal absorption is expected to be negligible for a large peptide (adult e=0), infant skin has higher surface-area-to-weight and an immature barrier so exposure is plausibly higher; therefore exposure score increased by +1 to e=1 for 0–3 yr skin. No infant-specific adverse data were identified in PubMed or regulatory sources. Sources: PubMed (no infant toxicity reports), CosIng, ECHA (no harmonised classification).
- Comment VeriMom évalue-t-il s-spider oligopeptide-1 ?
- VeriMom évalue s-spider oligopeptide-1 à 100/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à s-spider oligopeptide-1 pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à s-spider oligopeptide-1 basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.